Novo Nordisk AS is lowering prices of its top-selling WeGovy weight-loss drug in China, as the Danish drugmaker braces for intense competition from local rivals next year when the patent for its blockbuster treatment ends. Novo Nordisk slashed WeGovy prices by up to 37% in India last month. (Reuters) The company did not give details […]
Novo Nordisk A/S has cut the prices its weight-loss drug Wegovy by up to 37% in India, as the Danish drugmaker looks to hold its own against Eli Lilly & Co.’s Mounjaro in a country that’s home to the third largest obesity population in the world. Novo Nordisk will sell Poviztra 2.4 mg semaglutide injection […]
After Eli Lilly, Novo Nordisk has teamed up with an Indian partner to market its weight-loss drug under a new brand name in the world’s third most obese country. Novo Nordisk will sell Poviztra 2.4 mg semaglutide injection in India as a separate brand of its blockbuster weight-loss drug WeGovy. (Reuters) The Danish drugmaker will […]
